Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Study Number

1890021

Phase

Age Group

Adult

Principal Investigator

Purpose

This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma

Check your eligibility for this trial

Check now

Full Title

An open-label, multi-center, non-randomized phase I dose escalation study to investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 given as monotherapy in patients with relapsed or refractory T-cell Lymphoma

ClinicalTrials.Gov ID

NCT05079282

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.